VIDEO: Highlights in psoriasis from Maui Derm NP+PA
Click Here to Manage Email Alerts
In this Healio video exclusive from Maui Derm NP+PA Summer, meeting program director George Martin, MD, discusses highlights in the treatment of psoriasis.
Among the many treatments discussed, deucravacitinib stands out as highly effective, Martin, meeting director for the Maui Derm meeting, said.
“The beauty is, [deucravacitinib] has not inherited the legacy, the black box warning, that comes with other JAK inhibitors,” Martin said.
“It’s clear that inhibition of TYK2 is a real target,” he added.
In addition, Martin discusses what's in the pipeline, including the monoclonal antibody bimekizumab.
“We are seeing the highest efficacy we’ve ever seen for monoclonal antibodies for psoriasis,” Martin said.